Valneva SE VALN
NASDAQ VALN
$6.89 -0.17 (-2.41%)
At close: Sep 4, 2026 · 4:00 PM EDT

Valneva SE (VALN) Other Non-Current Liabilities (2020 - 2026)

Valneva SE (VALN) posted Other Non-Current Liabilities of $14.4 million for Q1 2026, up 6.4% sequentially from $13.6 million in Q4 2025, and up 140.16% YoY from $6.0 million in Q1 2025.

Analysis

Valneva SE (VALN) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends

Valneva SE has reported Other Non-Current Liabilities for 7 years, with the latest figure at $14.4 million in Q1 2026.

  • Quarterly Other Non-Current Liabilities rose 140.16% year-over-year to $14.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.4 million (up 140.16% YoY) and the FY2025 annual result came in at $13.6 million, up 2093.5% from the prior year.
  • Other Non-Current Liabilities climbed to $14.4 million in Q1 2026 per VALN's latest filing, from $13.6 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $60.7 million in Q2 2022 and troughed at $583453.1 in Q4 2024.
  • A 5-year average of $15.0 million and a median of $10.4 million in 2024 frame the typical range for Other Non-Current Liabilities.
  • The sharpest annual moves came in 2022 and 2025: Other Non-Current Liabilities plunged 85.2% in 2022, then soared 2226.08% in 2025.
  • Over 5 years, Other Non-Current Liabilities stood at $1.4 million in 2022, then retreated by 17.87% to $1.2 million in 2023, then plunged by 49.51% to $583453.1 in 2024, then surged by 2226.08% to $13.6 million in 2025, then rose by 6.4% to $14.4 million in 2026.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $14.4 million, $13.6 million, and $12.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Valneva SE 578.54 Mn 437.28 Mn 1.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.76 Mn
Mar 31, 2026 279,808.21
Dec 31, 2025 286,354.70
Sep 30, 2025 32,733.54
Jun 30, 2025 422,220.96
Mar 31, 2025 755,253.03
Dec 31, 2024 49,155.39
Sep 30, 2024 57,107.41
Jun 30, 2024 24,768.41
Mar 31, 2024 76,045.32
Dec 31, 2023 84,999.25
Sep 30, 2023 95,795.96
Jun 30, 2023 106,714.59
Mar 31, 2023 114,847.57
Dec 31, 2022 1.41 Mn
Sep 30, 2022 182,497.65
Jun 30, 2022 697,855.07
Mar 31, 2022 76,318.96
Dec 31, 2021 78,934.00
Dec 31, 2020 85,844.87